Abiraterone [154229-19-3]
A0534
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameAbiraterone [154229-19-3]
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionProgesterone derivative; Cyp17A1 inhibitor.
- UNSPSC12352200
References
- Ryan CJ, Cheng ML. Abiraterone acetate for the treatment of prostate cancer. Expert Opin Pharmacother. 2013 Jan;14(1):91-6. PMID: 23199349. Rehman Y, Rosenberg JE. Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer. Drug Des Devel Ther. 2012;6:13-8. PMID: 22291466. Soifer HS, Souleimanian N, Wu S, et al. Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells. J Biol Chem. 2012 Feb 3;287(6):3777-87. PMID: 22174412.